SCHEMBL3982902

SCHEMBL3982902

COc1ccc(-c2coc(C(=O)NN)c2-c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
POLB P06746 3/20 0.45
ALDH1A1 P00352 3/20 0.45
KMT2A Q03164 3/20 0.45
CTDSP1 Q9GZU7 2/20 0.45
GAA P10253 2/20 0.45
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 3/20 0.44
HTT P42858 2/20 0.44
BACE1 P56817 2/20 0.42
PIN1 Q13526 1/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HDAC4 P56524 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3977739 0.88 GAA (0.43) ALDH1A1KMT2AGAARAB9AMAPT
SCHEMBL3982880 0.85 KMT2A (0.54) POLBALDH1A1KMT2ACTDSP1GAA
SCHEMBL3978078 0.81 ALDH1A1 (0.51) POLBALDH1A1KMT2AGAARAB9A
SCHEMBL3977567 0.81 NR4A2 (0.51) CA1CA2POLBALDH1A1KMT2A
SCHEMBL4282784 0.81 CDC7 (0.45) ALDH1A1KMT2AGAAKDM4EMEN1
SCHEMBL3982883 0.81 PIN1 (0.40) POLBALDH1A1KMT2AGAARAB9A
SCHEMBL3982631 0.77 ALDH1A1 (0.41) POLBALDH1A1KMT2AGAARAB9A
SCHEMBL3981600 0.77 GAA (0.47) ALDH1A1KMT2AGAARAB9ALMNA
SCHEMBL3978704 0.77 OGG1 (0.46) POLBALDH1A1KMT2ACTDSP1GAA
SCHEMBL3976138 0.77 RAB9A (0.50) ALDH1A1KMT2AGAARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 CA1 877/4885CA2 221/4885POLB 4676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.